☆ 4.6 Letter

Real-world results of ibrutinib in relapsed/refractory CLL in France: Early results on a large series of 428 patients

AMERICAN JOURNAL OF HEMATOLOGY (2017)

Rate this paper

The primary rating indicates the level of overall quality for the paper. Secondary ratings independently reflect strengths or weaknesses of the paper.

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Real-world results of ibrutinib in relapsed/refractory CLL in France: Early results on a large series of 428 patients

Rate this paper

Find Funding. Review Successful Grants.

Find the ideal target journal for your manuscript

Export Citation

Share Paper